These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29410317)

  • 1. Secreted amyloid precursor protein alpha activates neuronal insulin receptors and prevents diabetes-induced encephalopathy.
    Aulston BD; Schapansky J; Huang Y; Odero GL; Glazner GW
    Exp Neurol; 2018 May; 303():29-37. PubMed ID: 29410317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.
    Stein TD; Anders NJ; DeCarli C; Chan SL; Mattson MP; Johnson JA
    J Neurosci; 2004 Sep; 24(35):7707-17. PubMed ID: 15342738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease.
    Tan VTY; Mockett BG; Ohline SM; Parfitt KD; Wicky HE; Peppercorn K; Schoderboeck L; Yahaya MFB; Tate WP; Hughes SM; Abraham WC
    Mol Brain; 2018 Feb; 11(1):7. PubMed ID: 29426354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
    Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
    J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway.
    Deng J; Habib A; Obregon DF; Barger SW; Giunta B; Wang YJ; Hou H; Sawmiller D; Tan J
    J Neurochem; 2015 Nov; 135(3):630-7. PubMed ID: 26342176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient increase in sAPPα secretion in response to Aβ1-42 oligomers: an attempt of neuronal self-defense?
    Rose C; Dorard E; Audrain M; Gorisse-Hussonnois L; Cartier N; Braudeau J; Allinquant B
    Neurobiol Aging; 2018 Jan; 61():23-35. PubMed ID: 29032190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic programming by the proteolytic fragments of the amyloid precursor protein: somewhere between confusion and clarity.
    Stein TD; Johnson JA
    Rev Neurosci; 2003; 14(4):317-41. PubMed ID: 14640319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer's disease.
    Rose C; Peoc'h K; Chasseigneaux S; Paquet C; Dumurgier J; Bourasset F; Calon F; Laplanche JL; Hugon J; Allinquant B
    BMC Neurosci; 2012 Jul; 13():84. PubMed ID: 22824057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylation.
    Tackenberg C; Nitsch RM
    Mol Brain; 2019 Mar; 12(1):27. PubMed ID: 30922360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway.
    Gakhar-Koppole N; Hundeshagen P; Mandl C; Weyer SW; Allinquant B; Müller U; Ciccolini F
    Eur J Neurosci; 2008 Sep; 28(5):871-82. PubMed ID: 18717733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.
    Jolivalt CG; Hurford R; Lee CA; Dumaop W; Rockenstein E; Masliah E
    Exp Neurol; 2010 Jun; 223(2):422-31. PubMed ID: 19931251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted amyloid precursor protein β and secreted amyloid precursor protein α induce axon outgrowth in vitro through Egr1 signaling pathway.
    Chasseigneaux S; Dinc L; Rose C; Chabret C; Coulpier F; Topilko P; Mauger G; Allinquant B
    PLoS One; 2011 Jan; 6(1):e16301. PubMed ID: 21298006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.
    Milosch N; Tanriöver G; Kundu A; Rami A; François JC; Baumkötter F; Weyer SW; Samanta A; Jäschke A; Brod F; Buchholz CJ; Kins S; Behl C; Müller UC; Kögel D
    Cell Death Dis; 2014 Aug; 5(8):e1391. PubMed ID: 25165877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
    Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration.
    Sagy-Bross C; Kasianov K; Solomonov Y; Braiman A; Friedman A; Hadad N; Levy R
    J Neurochem; 2015 Mar; 132(5):559-71. PubMed ID: 25533654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease.
    Wan J; Fu AK; Ip FC; Ng HK; Hugon J; Page G; Wang JH; Lai KO; Wu Z; Ip NY
    J Neurosci; 2010 May; 30(20):6873-81. PubMed ID: 20484629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein.
    Liskowsky W; Schliebs R
    Int J Dev Neurosci; 2006; 24(2-3):149-56. PubMed ID: 16423497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Amyloid Precursor Protein Alpha Interacts with alpha3-Na, K-ATPAse to Induce Axonal Outgrowth but Not Neuroprotection: Evidence for Distinct Mechanisms Underlying these Properties.
    Dorard E; Chasseigneaux S; Gorisse-Hussonnois L; Broussard C; Pillot T; Allinquant B
    Mol Neurobiol; 2018 Jul; 55(7):5594-5610. PubMed ID: 28983842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor.
    Kong Q; Peterson TS; Baker O; Stanley E; Camden J; Seye CI; Erb L; Simonyi A; Wood WG; Sun GY; Weisman GA
    J Neurochem; 2009 Jun; 109(5):1300-10. PubMed ID: 19317852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.